Last reviewed · How we verify

tretinoin microsphere 0.04% gel

Dermatrials Research · FDA-approved active Small molecule Quality 1/100

tretinoin microsphere 0.04% gel is a Small molecule drug developed by Dermatrials Research. It is currently FDA-approved. Also known as: Retin A micro 0.04%.

At a glance

Generic nametretinoin microsphere 0.04% gel
Also known asRetin A micro 0.04%
SponsorDermatrials Research
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about tretinoin microsphere 0.04% gel

What is tretinoin microsphere 0.04% gel?

tretinoin microsphere 0.04% gel is a Small molecule drug developed by Dermatrials Research.

Who makes tretinoin microsphere 0.04% gel?

tretinoin microsphere 0.04% gel is developed and marketed by Dermatrials Research (see full Dermatrials Research pipeline at /company/dermatrials-research).

Is tretinoin microsphere 0.04% gel also known as anything else?

tretinoin microsphere 0.04% gel is also known as Retin A micro 0.04%.

What development phase is tretinoin microsphere 0.04% gel in?

tretinoin microsphere 0.04% gel is FDA-approved (marketed).

Related